Cargando…
What will the cardiovascular disease slowdown cost? Modelling the impact of CVD trends on dementia, disability, and economic costs in England and Wales from 2020–2029
BACKGROUND: There is uncertainty around the health impact and economic costs of the recent slowing of the historical decline in cardiovascular disease (CVD) incidence and the future impact on dementia and disability. METHODS: Previously validated IMPACT Better Ageing Markov model for England and Wal...
Autores principales: | Collins, Brendan, Bandosz, Piotr, Guzman-Castillo, Maria, Pearson-Stuttard, Jonathan, Stoye, George, McCauley, Jeremy, Ahmadi-Abhari, Sara, Araghi, Marzieh, Shipley, Martin J., Capewell, Simon, French, Eric, Brunner, Eric J., O’Flaherty, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242440/ https://www.ncbi.nlm.nih.gov/pubmed/35767575 http://dx.doi.org/10.1371/journal.pone.0268766 |
Ejemplares similares
-
Forecasted trends in disability and life expectancy in England and Wales up to 2025: a modelling study
por: Guzman-Castillo, Maria, et al.
Publicado: (2017) -
Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study
por: Ahmadi-Abhari, Sara, et al.
Publicado: (2017) -
Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study
por: Bandosz, Piotr, et al.
Publicado: (2019) -
Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis
por: Pearson-Stuttard, Jonathan, et al.
Publicado: (2018) -
FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost‐Effectiveness Analysis
por: COLLINS, BRENDAN, et al.
Publicado: (2019)